Delivery Order SPE2DB22D3301-SPE2DB25FY6PT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Citalopram HBr 20 mg tablets (500-count) with a ceiling value of $3,132.17. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by August 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Citalopram HBR 20 mg tablets (500 count) with a ceiling value of $16,986.60. This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, represents a competitively awarded, non-set-aside contract executed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Citalopram HBR 40 mg tablets (500 count) valued at $3,705.96. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The performance location is AmerisourceBergen Drug Corp's corporate office in Conshohocken, Pennsylvania. Citalopram is a selective serotonin reuptake inhibitor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Citalopram HBR 40 mg tablets (500-count units) with a ceiling value of $12,406.14. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 tablets) on September 8, 2025, with an ultimate completion date of September 9, 2025. This contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $6,948.25 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Citalopram HBr 20 mg tablets (500 count). This competitive award utilizes firm fixed pricing with a completion date of September 8, 2025, and represents a non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,329.50 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies the place of performance as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child...
- The Defense Logistics Agency awarded a $16,451.57 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of 500 tablets of Citalopram HBR 40 mg, with completion expected by September 5, 2025. This competitively awarded contract utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count) with a ceiling value of $1,733.43. This competitive award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The contract is performed from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Citalopram HBr 10 mg tablets (500 count) with a ceiling value of $10,708.82. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY6PTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Citalopram HBr 20 mg tablets in quantities of 500 units, with a ceiling value of $61,596.66 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order for Citalopram HBr, a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety disorders, exemplifies the company's role in supporting military and veteran healthcare operations through routine pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.6k | 6/20/25 |